Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III

MLA

M.J. Reike, et al. “Biology of BCG Response in Non-Muscle Invasive Bladder Cancer - 2021 IBCN Updates Part III.” Urologic Oncology, May 2022. EBSCOhost, https://doi.org/10.1016/j.urolonc.2022.09.012⟩.

APA

M.J. Reike, M.A. Ingersoll, D.C. Müller, T.C.M. Zuiverloon, T. Strandgaard, A.M. Kamat, S.B. Williams, R. Seiler, T. Todenhöfer, L. Dyrskjøt, R. Nawroth, P. Goebell, B. Schmitz-Dräger, J.P. Sfakianos, J. Meeks, A. Horowitz, & P.C. Black. (2022). Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III. Urologic Oncology. https://doi.org/10.1016/j.urolonc.2022.09.012⟩

Chicago

M.J. Reike, M.A. Ingersoll, D.C. Müller, T.C.M. Zuiverloon, T. Strandgaard, A.M. Kamat, S.B. Williams, et al. 2022. “Biology of BCG Response in Non-Muscle Invasive Bladder Cancer - 2021 IBCN Updates Part III.” Urologic Oncology, May. doi:10.1016/j.urolonc.2022.09.012⟩.